Verified email-pattern data for Telesis Therapeutics, Inc. is currently limited. You can still use the company insights and contact sections below.
Telesis Therapeutics is an early stage biopharmaceutical company. We accelerate the development of breakthrough discoveries acquired from research institutions into medicines for patients. We currently focus on drug development and commercialization in oncology.
We acquire early stage assets with issued or pending IP and positive biologic signals. Our business model encompasses discovery research, IND enabling studies, and clinical development. We identify, develop, de-risk, and commercialize assets, or we strategically partner or license our assets for later stage development and commercialization.
We have acquired our first oncology asset, TTL-315, a small molecule antimetabolite to treat solid tumors. The published preclinical data for this asset, includes: cell, animal, and early toxicology. This molecule has a global IP portfolio. We seek public and private funding to support further research and development, and partnerships and collaborations. Our recent collaboration with the NCI's Fredrick National Laboratory for Cancer Research (FNLCR) is significant. We have executed a cooperative research and development agreement (CRADA) with the FNLCR. The preclinical development program and resulting research will help prepare TTL-315 for clinical translation.
Our initial therapeutic target is for the treatment of patients with solid tumors, specifically for pancreatic ductal adenocarcinoma (PDAC). This deadly cancer has a high unmet medical need, and we will secure an Orphan Drug designation. This will offer TTL-315 extended patent life, and an opportunity for accelerated regulatory and development pathways. Follow on indications will include, small cell lung and colorectal cancers.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 3711 Market Street, Suite 800, Philadlephia,pa - Pennsylvania 19104,united States
- Industry
- Pharmaceutical Manufacturing
- HQ
- Philadlephia, PA - Pennsylvania
Telesis Therapeutics, Inc. Questions
Telesis Therapeutics, Inc.'s website is http://www.telesistherapeutics.com
Telesis Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/telesis-therapeutics-llc
Telesis Therapeutics, Inc. has
3 employees.
View email and phone details for 3
employees at Telesis Therapeutics, Inc..
Telesis Therapeutics, Inc.'s industry is
Pharmaceutical Manufacturing
Telesis Therapeutics, Inc.'s top competitors are
Neox Biotech,
Mc Sciences,
Epigen Biosciences, Inc.,
Quad.bio,
Mirabiologics Inc.,
Hope Medicine Inc,
Novamab,
New Perspectives, Inc.,
Rezq Bio,
Renbiologics.
Telesis Therapeutics, Inc.'s categories are Pharmaceutical Manufacturing
Telesis Therapeutics, Inc.'s founding year is 2015
Explore related pages
Related company profiles:
Companies like Telesis Therapeutics, Inc.
Top Telesis Therapeutics, Inc. Employees
-
Thurman White
Board Member | Advisor | Angel Investor…
San Francisco, California, United States, United States6ceoprogressinvestment.com, ceoprogressinvestment.com, vineyardbank.com, progressinvestment.com, progressinvestment.com, progressinvestment.com3 +141551XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.